← Back to Search

Other

Experimental Formula for Blood Sugar Control

N/A
Waitlist Available
Research Sponsored by Abbott Nutrition
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0 to 240 minutes
Awards & highlights

Study Summary

This is a randomized, controlled, crossover study to compare the effects to two treatments on postprandial glucose in adults with type 2 diabetes.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0 to 240 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0 to 240 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Glucose positive area under the curve (AUC)
Secondary outcome measures
Glucose Concentrations
Glucose peak time
Glucose peak value
+4 more
Other outcome measures
Appetite Questionnaire
Glucagon-Like Peptide-1 (GLP-1) concentrations
Glucagon-Like Peptide-1 (GLP-1) peak time
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental FormulaExperimental Treatment1 Intervention
One 296 mL serving of study product
Group II: Test MealActive Control1 Intervention
48 g Instant oatmeal

Find a Location

Who is running the clinical trial?

Abbott NutritionLead Sponsor
168 Previous Clinical Trials
33,480 Total Patients Enrolled
Sara Thomas, PhD, RDNStudy ChairAbbott Nutrition
2 Previous Clinical Trials
52 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~8 spots leftby Apr 2025